Anti-LCK monoclonal antibody

Pre-made anti-LCK monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LCK/LCK products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T12499-Ab-1/ GM-Tg-hg-T12499-Ab-2Anti-Human LCK monoclonal antibodyHuman
GM-Tg-rg-T12499-Ab-1/ GM-Tg-rg-T12499-Ab-2Anti-Rat LCK monoclonal antibodyRat
GM-Tg-mg-T12499-Ab-1/ GM-Tg-mg-T12499-Ab-2Anti-Mouse LCK monoclonal antibodyMouse
GM-Tg-cynog-T12499-Ab-1/ GM-Tg-cynog-T12499-Ab-2Anti-Cynomolgus/ Rhesus macaque LCK monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T12499-Ab-1/ GM-Tg-felg-T12499-Ab-2Anti-Feline LCK monoclonal antibodyFeline
GM-Tg-cang-T12499-Ab-1/ GM-Tg-cang-T12499-Ab-2Anti-Canine LCK monoclonal antibodyCanine
GM-Tg-bovg-T12499-Ab-1/ GM-Tg-bovg-T12499-Ab-2Anti-Bovine LCK monoclonal antibodyBovine
GM-Tg-equg-T12499-Ab-1/ GM-Tg-equg-T12499-Ab-2Anti-Equine LCK monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T12499-Ab-1/ GM-Tg-hg-T12499-Ab-2; GM-Tg-rg-T12499-Ab-1/ GM-Tg-rg-T12499-Ab-2;
GM-Tg-mg-T12499-Ab-1/ GM-Tg-mg-T12499-Ab-2; GM-Tg-cynog-T12499-Ab-1/ GM-Tg-cynog-T12499-Ab-2;
GM-Tg-felg-T12499-Ab-1/ GM-Tg-felg-T12499-Ab-2; GM-Tg-cang-T12499-Ab-1/ GM-Tg-cang-T12499-Ab-2;
GM-Tg-bovg-T12499-Ab-1/ GM-Tg-bovg-T12499-Ab-2; GM-Tg-equg-T12499-Ab-1/ GM-Tg-equg-T12499-Ab-2
Products NameAnti-LCK monoclonal antibody
Formatmab
Target NameLCK
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LCK monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T12499-Ag-1Recombinant multi-species LCK/ IMD22/ LSK protein
    ORF Viral VectorpGMLPm005214mouse Lck Lentivirus plasmid
    ORF Viral VectorvGMLPm005214mouse Lck Lentivirus particle


    Target information

    Target IDGM-T12499
    Target NameLCK
    Gene ID3932,16818,313050,717704,478151,101098805,508890,100146139
    Gene Symbol and SynonymsHck-3,IMD22,LCK,Lck1,Lcktkr,LSK,Lskt,p56-LCK,p56,p56lck,pp58lck,YT16
    Uniprot AccessionP06239,Q01621
    Uniprot Entry NameLCK_HUMAN,LCK_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000182866
    Target ClassificationKinase, Tumor-associated antigen (TAA)

    The target: LCK, gene name: LCK, also named as IMD22, LSK, YT16, p56lck, pp58lck. This gene is a member of the Src family of protein tyrosine kinases (PTKs). The encoded protein is a key signaling molecule in the selection and maturation of developing T-cells. It contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. The protein localizes to the plasma membrane and pericentrosomal vesicles, and binds to cell surface receptors, including CD4 and CD8, and other signaling molecules. Multiple alternatively spliced variants encoding different isoforms have been described. [provided by RefSeq, Aug 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.